Expedition Medicines
PrivateLast Round
Seed
Oct 22, 2025
Total Funding Raised
$50M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Expedition Medicines is a biotechnology company that is building an AI platform to generate small molecule drugs against disease-driving proteins that have long been considered undruggable.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Expedition Medicines Comparables
Compare Expedition Medicines with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Empress Therapeutics | 79% | |
| Metaphore Biotechnologies | 77% | |
| Think Bioscience | 76% |
Expedition Medicines Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 22, 2025 |
Expedition Medicines Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Flagship Pioneering | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 19, 2026
Monthly visitors increased 82% MoM.
- Feb 23, 2026
Grew 21% QoQ from 38 to 46 employees.
Expedition Medicines Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Expedition Medicines's valuation, stock price, and market status.
Is Expedition Medicines a public or private company?
Expedition Medicines is a private company.
What is the current stock price of Expedition Medicines?
Expedition Medicines is a private company, so its shares have no public market price. Caplight tracks Expedition Medicines's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Expedition Medicines worth (valuation)?
Valuation information for Expedition Medicines is not publicly available.
Can I buy Expedition Medicines stock?
Expedition Medicines shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Expedition Medicines's last funding round?
Expedition Medicines's most recent funding round was Seed on October 22, 2025.
Who are the main investors in Expedition Medicines?
Key investors in Expedition Medicines include Flagship Pioneering.
Will Expedition Medicines IPO soon?
No public IPO plans have been announced for Expedition Medicines.
How can I track Expedition Medicines secondary market activity?
Caplight tracks bids, offers, and trades in Expedition Medicines's shares on secondary markets.